Watchlist Price Alert

Braxia Scientific Corp. (BRAXF)

OTC: BRAXF · Real-Time Price · USD

0.00

-0.00 (-100.00%)

At close: Jun 06, 2025, 10:51 AM

Braxia Scientific Balance Sheet Statement

Financials in CAD. Fiscal year is April - March.

Fiscal Year	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020
Period Ending	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Cash & Equivalents	128.34K	709.68K	861.39K	1.46M	1.49M	5.18M	7.68M	8.68M	7.64M	9.61M	10.26M	11.1M	11.79M	12.6M	14.16M	1.52M	705.38K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	8.21K	20.11K	50.58K	40.86K	66.83K	60.75K	52.69K	34.56K	n/a	6.85K	4.65K	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	-1.68M	-1.73M	-7.36M	-8.26M	-2.22M	-1.97M	-7.1M	-7.11M	-7.09M	-7.09M	-7.12M	-7.11M	-7.11M	n/a	n/a
Receivables	91.03K	71.5K	82K	408.93K	216.56K	181.32K	111.03K	225.42K	197.03K	152.46K	131.59K	113.44K	243.91K	213.68K	n/a	208.01K	12.15K
Inventory	n/a	n/a	-0.00	8.68K	9.38K	79.98K	n/a	n/a	n/a	n/a	n/a	n/a	-243.91K	33.46K	33.46K	117.37K	106.53K
Other Current Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	397.07K	894.13K	1.02M	2.16M	2.04M	5.5M	8.6M	9.66M	8.35M	9.78M	10.45M	11.4M	12.54M	13.46M	14.87M	2.2M	904.7K
Property-Plant & Equipment	1.07M	1.13M	764.88K	819.56K	831.32K	847.8K	399.26K	168.35K	53.31K	56.36K	45.74K	50.37K	31.47K	22.44K	22.92K	11.08K	n/a
Goodwill & Intangibles	868.06K	868.06K	868.06K	868.06K	6.46M	7.36M	1.77M	1.77M	7.04M	7.04M	7.04M	7.04M	7.08M	7.09M	7.09M	11.86M	114.93K
Total Long-Term Assets	1.94M	2.02M	1.68M	1.73M	7.36M	8.26M	2.22M	1.97M	7.1M	7.11M	7.09M	7.09M	7.56M	7.61M	7.62M	11.87M	114.93K
Total Assets	2.34M	2.91M	2.71M	3.88M	9.39M	13.76M	10.82M	11.63M	15.44M	16.89M	17.55M	18.49M	20.1M	21.07M	22.49M	14.07M	1.02M
Account Payables	1.39M	1.3M	1.26M	1.09M	643.7K	627.71K	559.54K	660.37K	1.78M	1.9M	1.9M	1.98M	1.51M	999.01K	513.64K	63.99K	45.91K
Deferred Revenue	57.56K	59.26K	66.91K	101.1K	87.15K	96.72K	98.28K	26.45K	20.3K	30.48K	27.2K	22.65K	18.18K	16.15K	19.5K	n/a	n/a
Short-Term Debt	49.97K	49.97K	49.97K	49.97K	49.97K	587.75K	49.97K	49.97K	49.97K	49.97K	49.97K	49.97K	53.83K	49.97K	49.97K	n/a	n/a
Other Current Liabilities	123.78K	183.04K	190.69K	224.87K	356.81K	374.09K	338.37K	266.54K	305.66K	315.83K	312.56K	308.01K	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	2.2M	1.86M	1.78M	2.15M	1.32M	3.18M	2.47M	2.54M	2.64M	2.5M	2.33M	2.55M	1.63M	1.11M	631K	75.07K	60.91K
Long-Term Debt	58.14K	57.18K	56.23K	55.31K	55.72K	54.64K	53.58K	52.55K	51.55K	50.55K	49.57K	48.62K	43.83K	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	501.04K	521.66K	126.85K	131.3K	135.22K	139.18K	141.23K	133.61K	51.55K	50.55K	49.57K	48.62K	43.83K	n/a	2.56K	n/a	n/a
Total Liabilities	2.7M	2.38M	1.9M	2.28M	1.45M	3.32M	2.61M	2.67M	2.69M	2.56M	2.38M	2.6M	1.67M	1.11M	633.56K	75.07K	60.91K
Total Debt	636.63K	546.32K	90.99K	151.85K	157.2K	697.49K	162.13K	164.51K	101.52K	101.84K	104.75K	58.94K	97.66K	49.97K	49.97K	11.08K	n/a
Common Stock	100.43M	100.43M	100.43M	100.43M	99.16M	99.8M	96.93M	96.93M	94.39M	94.39M	94.33M	93.98M	93.98M	93.98M	93.98M	15.6M	1.27M
Retained Earnings	-118.01M	-117.1M	-116.83M	-116.03M	-108.37M	-106.2M	-103.86M	-102.89M	-96.08M	-93.55M	-91.84M	-90.75M	-88.16M	-86.62M	-84.69M	-3.09M	-321.21K
Comprehensive Income	17.22M	17.21M	17.21M	17.21M	17.15M	16.84M	15.13M	14.92M	14.44M	13.5M	12.68M	12.66M	12.34M	12.34M	12.31M	1.48M	10.43K
Shareholders Equity	-365.84K	535.16K	803.89K	1.6M	7.94M	10.44M	8.2M	8.96M	12.75M	14.34M	15.17M	15.89M	18.42M	19.96M	21.85M	13.99M	958.72K
Total Investments	8.21K	20.11K	50.58K	40.86K	66.83K	60.75K	52.69K	34.56K	n/a	6.85K	4.65K	n/a	n/a	n/a	n/a	n/a	n/a